$ALKS Cashflow Statement | Understand Stock

$ALKS

$44.32 -$0.12 (0.27%) Close

$ALKS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization
Share-based compensation expense
Deferred income taxes
Change in the fair value of contingent consideration
Loss on debt extinguishment
Payment made for debt modification
Impairment of investment in Synchronicity Pharma, Inc.
Other non-cash charges

Changes in assets and liabilities:
Receivables
Contract assets
Inventory
Prepaid expenses and other assets
Right-of-use assets
Accounts payable and accrued expenses
Accrued sales discounts, allowances and reserves
Contract liabilities
Operating lease liabilities
Other long-term liabilities
Cash flows provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions of property, plant and equipment
Proceeds from the sale of property, plant and equipment
Proceeds from contingent consideration
Return of Fountain Healthcare Partners II, L.P. investment
Payment made for licensed Intellectual Property ("IP")
Proceeds from the sale of the Athlone Facility
Purchases of investments
Sales and maturities of investments
Cash flows provided by (used in) investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Cash transferred to Mural Oncology plc at separation
Proceeds from the issuance of ordinary shares under share-based compensation arrangements
Employee taxes paid related to net share settlement of equity awards
Proceeds from the issuance of long-term debt
Payment for the repurchase of ordinary shares
Payment made for debt extinguishment
Prepayment of long-term debt
Principal payments of long-term debt
Cash flows provided by (used in) financing activities

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - Beginning of period
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - End of period
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents
Restricted cash
SUPPLEMENTAL CASH FLOW DISCLOSURE:
Cash paid for interest
Cash paid for taxes
Non-cash investing and financing activities:
Purchased capital expenditures included in accounts payable and accrued expenses

Comments